Medical device maker Dexcom (DXCM -13.3%) takes a hit after its Q3 misses across the board, hurt...

|By:, SA News Editor

Medical device maker Dexcom (DXCM -13.3%) takes a hit after its Q3 misses across the board, hurt by lagging international sales and higher operational costs. The company says the declining sales trend is likely to continue, and lowers FY11 guidance. It now expects revenue in the range of $62.5M - $67.5M, down from prior estimates of $67.5- $72.5M. Separately, Morgan Keegan cuts the shares to Market Perform off the results.